U.S. market Closed. Opens in 1 day 10 hours 15 minutes

PROK | ProKidney Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue3.17M3.04M1.98MN/AN/A
Gross Profit-3.17M-3.04M-1.98MN/AN/A
Operating Expenses148.35M153.01M55.11M27.02M79.38M
Selling, General & Admin41.65M70.94M8.86M5.98M4.16M
Research & Development106.71M82.07M46.26M21.04M75.22M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-151.52M-153.01M-55.11M-27.02M-19.16M
Other Expenses / Income22.07M5.77M2.00K43.00K-60.09M
Before Tax Income-129.45M-147.24M-55.11M-26.98M-79.25M
Income Tax Expenses6.00M896.00K38.00K-232.00K361.00K
Net Income-35.47M-148.13M-55.15M-26.75M-79.61M
Interest Expenses12.00K215.00KN/AN/AN/A
Basic Shares Outstanding61.71M61.54M186.50M186.50M78.53M
Diluted Shares Outstanding61.71M61.54M186.50M186.50M78.53M
EBITDA-148.35M-143.99M-53.13M-26.02M-18.29M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-29.46M-147.02M-55.11M-26.98M-79.25M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙